Prodrug Bioavailability

Prodrug Bioavailability is the fraction and rate at which the active drug moiety, following enzymatic or chemical conversion from its pharmacologically inactive prodrug form, becomes available at the systemic circulation and target sites of action within the body.

76

Publications

2.5K

Citations

371

Authors

95

Institutions

Publications per year

2017–2026

11

Authors

371

  1. CL
    Claus Larsen

    University of Copenhagen, Denmark

    6 publications · 163 citations

    6

    h-index

  2. BC
    Bernd Clement

    Christian-Albrechts-Universität zu Kiel, Germany

    6 publications · 284 citations

    6

    h-index

  3. CD
    Cheng Der Yu

    University of Michigan, United States

    5 publications · 233 citations

    5

    h-index

  4. NF
    Norman F.H. Ho

    University of Michigan, United States

    5 publications · 233 citations

    5

    h-index

  5. JL
    Jeffrey L. Fox

    University of Utah, United States

    5 publications · 233 citations

    5

    h-index

1–5 of 371

Venues

  1. Journal of Pharmaceutical Sciences

    13 publications · 450 citations

    12

    h-index

  2. Journal of Medicinal Chemistry

    8 publications · 480 citations

    8

    h-index

  3. International Journal of Pharmaceutics

    7 publications · 181 citations

    7

    h-index

  4. Molecular Pharmaceutics

    4 publications · 76 citations

    4

    h-index

  5. Bioorganic & Medicinal Chemistry Letters

    3 publications · 77 citations

    3

    h-index

1–5